Backes FJ, Wei L, Chen M, Hill K, et al. Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer. Gynecol Oncol 2021 Jul 13. pii: S0090-8258(21)00528.
PMID: 34272090